Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Probable calcium-transporting ATPase KIAA0703 | 0.0065 | 0.0106 | 0.0238 |
Mycobacterium ulcerans | metal cation transporter p-type ATPase a | 0.0259 | 0.4269 | 1 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 1 | 0.0093 | 0.07 | 0.7455 |
Onchocerca volvulus | 0.0436 | 0.8049 | 0.6596 | |
Echinococcus granulosus | nervana 2 | 0.0436 | 0.8049 | 0.7902 |
Leishmania major | calcium-transporting ATPase, putative | 0.0102 | 0.0902 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0436 | 0.8049 | 0.7902 |
Echinococcus multilocularis | nervana 2 | 0.0527 | 1 | 1 |
Leishmania major | calcium motive p-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase 2 | 0.0102 | 0.0902 | 0.0218 |
Entamoeba histolytica | calcium-transporting P-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0102 | 0.0902 | 0.0218 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0527 | 1 | 1 |
Schistosoma mansoni | calcium-transporting atpase 2 (atpase 2) | 0.0102 | 0.0902 | 0.0218 |
Toxoplasma gondii | sarco/endoplasmic reticulum Ca2+-ATPase | 0.0102 | 0.0902 | 1 |
Echinococcus granulosus | nervana 2 | 0.0527 | 1 | 1 |
Schistosoma mansoni | sodium / potassium ATPase beta chain | 0.0436 | 0.8049 | 0.7902 |
Giardia lamblia | Potassium-transporting ATPase alpha chain 1 | 0.0269 | 0.4472 | 1 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0436 | 0.8049 | 0.7902 |
Echinococcus multilocularis | sodium:potassium transporting ATPase subunit | 0.0527 | 1 | 1 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Echinococcus multilocularis | calcium transporting ATPase type 2C member | 0.0102 | 0.0902 | 0.0218 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0102 | 0.0902 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0527 | 1 | 1 |
Echinococcus multilocularis | plasma membrane calcium transporting ATPase | 0.0102 | 0.0902 | 0.0218 |
Echinococcus granulosus | nervana 2 | 0.0436 | 0.8049 | 0.7902 |
Echinococcus multilocularis | Tetracycline resistance leader peptide, TetL | 0.0102 | 0.0902 | 0.0218 |
Plasmodium falciparum | calcium-transporting ATPase | 0.0102 | 0.0902 | 0.5 |
Trypanosoma brucei | calcium motive p-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0527 | 1 | 1 |
Echinococcus granulosus | Na:K ATPase alpha subunit | 0.0269 | 0.4472 | 0.4056 |
Mycobacterium leprae | PROBABLE CATION-TRANSPORTER ATPASE I CTPI | 0.0222 | 0.3473 | 0.5 |
Loa Loa (eye worm) | sodium/potassium-transporting ATPase subunit alpha | 0.0232 | 0.3676 | 0.3608 |
Plasmodium vivax | P-type ATPase4, putative | 0.0102 | 0.0902 | 0.5 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0102 | 0.0902 | 0.0218 |
Echinococcus multilocularis | nervana 2 | 0.0436 | 0.8049 | 0.7902 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0093 | 0.07 | 0.7755 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.2571 | 0.2491 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 2 | 0.0093 | 0.07 | 0.7455 |
Toxoplasma gondii | P-type ATPase4, putative | 0.0102 | 0.0902 | 1 |
Toxoplasma gondii | plasma membrane-type Ca(2+)-ATPase A1 PMCAA1 | 0.0102 | 0.0902 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0527 | 1 | 1 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0102 | 0.0902 | 0.0218 |
Echinococcus granulosus | nervana 2 | 0.0527 | 1 | 1 |
Brugia malayi | Membrane calcium atpase protein 3 | 0.0102 | 0.0902 | 0.2018 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0093 | 0.07 | 0.7755 |
Echinococcus granulosus | calcium transporting atpase | 0.0102 | 0.0902 | 0.0218 |
Trypanosoma cruzi | Calcium ATPase SERCA-like | 0.0093 | 0.07 | 0.7455 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0527 | 1 | 1 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0102 | 0.0902 | 0.0218 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0093 | 0.07 | 0.7455 |
Trypanosoma brucei | calcium-translocating P-type ATPase | 0.0102 | 0.0902 | 1 |
Plasmodium vivax | calcium-transporting ATPase, putative | 0.0102 | 0.0902 | 0.5 |
Echinococcus multilocularis | calcium transporting atpase | 0.0102 | 0.0902 | 0.0218 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0436 | 0.8049 | 0.7902 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0102 | 0.0902 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0209 | 0.3186 | 0.3112 |
Echinococcus multilocularis | Na+:K+ ATPase alpha subunit | 0.0269 | 0.4472 | 0.4056 |
Echinococcus granulosus | calcium transporting ATPase type 2C member | 0.0102 | 0.0902 | 0.0218 |
Schistosoma mansoni | na+/k+ atpase alpha subunit | 0.0269 | 0.4472 | 0.4056 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.2283 | 0.22 |
Leishmania major | P-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Echinococcus granulosus | sodium:potassium transporting ATPase subunit | 0.0527 | 1 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0527 | 1 | 1 |
Loa Loa (eye worm) | Na,K-ATPase alpha subunit | 0.0269 | 0.4472 | 0.4412 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase, putative | 0.0093 | 0.07 | 0.7455 |
Brugia malayi | Sodium/potassium-transporting ATPase alpha chain, putative | 0.0232 | 0.3676 | 0.822 |
Echinococcus multilocularis | Ca2+ transporting ATPase plasma membrane | 0.0102 | 0.0902 | 0.0218 |
Schistosoma mansoni | Na+/K+ transporting ATPase subunit alpha | 0.0269 | 0.4472 | 0.4056 |
Schistosoma mansoni | transmemberane protein | 0.0527 | 1 | 1 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0102 | 0.0902 | 1 |
Plasmodium falciparum | non-SERCA-type Ca2+ -transporting P-ATPase | 0.0102 | 0.0902 | 0.5 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0093 | 0.07 | 0.7455 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase | 0.0102 | 0.0902 | 0.0218 |
Echinococcus granulosus | Ca2 transporting ATPase plasma membrane | 0.0102 | 0.0902 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0269 | 0.4472 | 0.4412 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0093 | 0.07 | 0.7755 |
Onchocerca volvulus | 0.0527 | 1 | 1 | |
Brugia malayi | Na,K-ATPase alpha subunit | 0.0269 | 0.4472 | 1 |
Brugia malayi | Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type | 0.0102 | 0.0902 | 0.2018 |
Echinococcus multilocularis | nervana 2 | 0.0436 | 0.8049 | 0.7902 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.07 | 0.06 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 16 ug ml-1 | Antibacterial activity against Escherichia coli CAN-ICU 63074 after 24 hrs by macrobroth dilution method | ChEMBL. | 20373816 |
MIC (functional) | = 32 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by macrobroth dilution method | ChEMBL. | 20373816 |
MIC (functional) | = 32 ug ml-1 | Antibacterial activity against gentamicin-resistant Escherichia coli ATCC 6174 after 24 hrs by macrobroth dilution method | ChEMBL. | 20373816 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.